imatinib mesylate has been researched along with Stevens-Johnson Syndrome in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (77.78) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bois, E; Farooq, U; Holle, LM | 1 |
| Chan, AL; Hsieh, HJ; Lin, SJ | 1 |
| Himanshu, D; Jain, N; Jha, P; Singh, AK | 1 |
| Alomar, A; Puig, L; Sureda, A; Vidal, D | 1 |
| Crossman, LC; O'Brien, SG; Rule, SA | 1 |
| Bornhäuser, M; Ehninger, G; Illmer, T; Schaich, M; Schäkel, K | 1 |
| Ardau, R; Chillotti, C; De Lisa, R; Del Zompo, M; Severino, G | 1 |
| Kumar, R; Mahapatra, M; Mishra, P | 1 |
| Chen, PM; Chiou, TJ; Chung, HM; Fan, FS; Hsiao, LT; Lin, JT; Liu, JH; Wang, WS; Yen, CC | 1 |
9 other study(ies) available for imatinib mesylate and Stevens-Johnson Syndrome
| Article | Year |
|---|---|
Late onset imatinib-induced Stevens-Johnson syndrome.
Topics: Antineoplastic Agents; Benzamides; Humans; Imatinib Mesylate; Male; Piperazines; Pyrimidines; Stevens-Johnson Syndrome; Time Factors; Young Adult | 2014 |
Stevens-Johnson syndrome induced by combination of imatinib and allopurinol.
Topics: Aged, 80 and over; Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Chronic Disease; Female; Humans; Imatinib Mesylate; Kidney Failure, Chronic; Leukemia, Myeloid; Piperazines; Pyrimidines; Stevens-Johnson Syndrome | 2009 |
Imatinib-induced Stevens-Johnsons syndrome.
Topics: Antineoplastic Agents; Benzamides; Biopsy; Diagnosis, Differential; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Stevens-Johnson Syndrome | 2013 |
Sti571-induced Stevens-Johnson Syndrome.
Topics: Antineoplastic Agents; Benzamides; Chronic Disease; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Pyrimidines; Stevens-Johnson Syndrome | 2002 |
Managing cutaneous reactions to imatinib therapy.
Topics: Adult; Aged; Benzamides; Drug Eruptions; Exanthema; Female; Humans; Imatinib Mesylate; Immunosuppressive Agents; Immunotherapy; Leukemia, Myeloid, Chronic-Phase; Piperazines; Prednisolone; Pyrimidines; Stevens-Johnson Syndrome | 2002 |
Severe epidermal necrolysis after treatment with imatinib and consecutive allogeneic hematopoietic stem cell transplantation.
Topics: Benzamides; Fatal Outcome; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Pyrimidines; Steroids; Stevens-Johnson Syndrome; Transplantation, Homologous | 2003 |
Adverse reactions during imatinib and lansoprazole treatment in gastrointestinal stromal tumors.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antineoplastic Agents; Benzamides; Drug Eruptions; Edema; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Lansoprazole; Middle Aged; Omeprazole; Piperazines; Proton Pump Inhibitors; Pyrimidines; Stevens-Johnson Syndrome | 2005 |
Imatinib-induced Stevens-Johnson syndrome: recurrence after re-challenge with a lower dose.
Topics: Benzamides; Dose-Response Relationship, Drug; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Recurrence; Stevens-Johnson Syndrome | 2007 |
Stevens-Johnson syndrome after treatment with STI571: a case report.
Topics: Adult; Antineoplastic Agents; Benzamides; Drug Eruptions; Enzyme Inhibitors; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Stevens-Johnson Syndrome | 2002 |